Companies/Body and Mind Inc.
Company profile

Body and Mind Inc.

OTC: BMMJ · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Vancouver, BCCIK 0001715611Reports USD
#532 of 1,418 Healthcare companies by revenuebottom-quartile growth
EA Score
Revenue TTM
$14.3M
Rev growth YoY (TTM)
-48.9%
Net income (FY)
-$20.6M
Employees
142
as of 2026-08-29
Market cap
$494.7k
as of 2026-08-29

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$22.8M$22.8M2023
Net income-$20.6M-$20.6M2023
Operating income-$7.7M-$7.7M2023
Total assets$21.2M$21.2M2023
Liabilities$30.5M$30.5M2023
Equity-$10.3M-$10.3M2023

Revenue trend

FY2018 – FY2023 · USD
FY18
FY19
FY20
FY21
FY22
FY23

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Body and Mind Inc.’s revenue?

Body and Mind Inc. booked $22.8M in FY2023 revenue, contracting 28% year over yearslower than 75% of Healthcare companies we track, at a -90.1% net margin.

Key facts
CEOMichael Mills
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersVancouver, BC
ExchangeOTC: BMMJ
Employees142
IPO date2012-02-22
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.